BIOMAT Database Logo BIOMAT Database Logo

Skipping along: an exon skipping therapy shows promise for Duchenne muscular dystrophy. 2011

A K Hawkins
Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada. alicehaw@exchange.ubc.ca

UI MeSH Term Description Entries

Related Publications

A K Hawkins
Exon skipping therapy for Duchenne muscular dystrophy.
June 2015, Advanced drug delivery reviews,
A K Hawkins
Exon-skipping therapy for Duchenne muscular dystrophy.
August 2011, Lancet (London, England),
A K Hawkins
[Exon-skipping therapy for Duchenne muscular dystrophy].
November 2011, Rinsho shinkeigaku = Clinical neurology,
A K Hawkins
Exon-skipping therapy for Duchenne muscular dystrophy.
August 2009, Neuropathology : official journal of the Japanese Society of Neuropathology,
A K Hawkins
Exon-skipping therapy for Duchenne muscular dystrophy.
January 2012, Lancet (London, England),
A K Hawkins
Exon-skipping advances for Duchenne muscular dystrophy.
August 2018, Human molecular genetics,
A K Hawkins
Exon-Skipping in Duchenne Muscular Dystrophy.
January 2021, Journal of neuromuscular diseases,
A K Hawkins
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD).
January 2011, Artificial DNA, PNA & XNA,
A K Hawkins
Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.
October 2017, Journal of human genetics,
A K Hawkins
CRISPR therapy shows promise in Duchenne muscular dystrophy.
November 2018, Nature reviews. Neurology,
Copied contents to your clipboard!